Suchergebnisse - "Kamel-Reid, Suzanne"

PubPharm (317)

1

Effects of Ethnicity on Outcomes of Patients With EGFR Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection

enthalten in: JTO clinical and research reports | 2022

von Sung, M. | Tomasini, P. | Le, L. | +8

2

BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase

enthalten in: British journal of haematology | 2022

von Kim, D. | Kim, T. | Atenafu, E. | +15

3

BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase

enthalten in: British Journal of Haematology | 2022

von Kim, D. | Kim, T. | Atenafu, E. | +15

4

The Prevent Ovarian Cancer Program (POCP) : Identification of women at risk for ovarian cancer using complementary recruitment approaches

enthalten in: Gynecologic oncology | 2021

von Tone, A. | McCuaig, J. | Ricker, N. | +18

5

Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial

enthalten in: British journal of haematology | 2021

von Kim, D. | Novitzky-Basso, I. | Kim, T. | +15

CommentIn: Br J Haematol. 2021 May;193(4):699-700. - PMID 33876424

6

Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia

enthalten in: Haematologica | 2021

von Puckrin, R. | Atenafu, E. | Claudio, J. | +13

7

Multisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumours

enthalten in: PloS one | 2021

von Bartlett, J. | Amemiya, Y. | Arts, H. | +14

8

Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial

enthalten in: British Journal of Haematology | 2021

von Kim, D. | Novitzky‐Basso, I. | Kim, T. | +15

9

Multicenter Validation Study to Implement Plasma Epidermal Growth Factor Receptor T790M Testing in Clinical Laboratories

enthalten in: JCO precision oncology | 2020

von Leighl, N. | Kamel-Reid, S. | Cheema, P. | +17

10

Genome analysis and data sharing informs timing of molecular events in pancreatic neuroendocrine tumour

enthalten in: bioRxiv.org | 2020

von Quevedo, R. | Spreafico, A. | Bruce, J. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]